Dry mouth and acid exposure can raise your risk
A number of LDHA/B inhibitors, such as FX-11, Galloflavin, and N-hydroxyindole-based compounds, have been explored in animal or preclinical studies for cancer treatment, as summarized in Table 3
I think it is only fair to the patients to inform them of the potential risk
Billing 96372 under a facility POS when services were rendered in an office triggers automatic review at most payers Multiple injections: Modifier 59 or XS distinguishes each additional injection from the first when multiple units are billed on the same date Modifiers for CPT Code 96372 Modifier selection is where most 96372 claims go wrong
ClinicalTrials.gov registration: NCT06659744, NCT07088718, NCT07096063
The short answer is: yes, and often with synergistic benefits